Nanosensors are highly sensitive devices that can monitor biological changes at the molecular level. They can detect the presence of metastatic cells by identifying specific biomarkers in blood or tissue samples. This real-time monitoring enables healthcare providers to assess the progression of metastasis and adjust treatment plans accordingly.
